222 related articles for article (PubMed ID: 1478348)
1. Cell line issues related to specific expression vectors: retrovirus vectors.
Morgan EM
Dev Biol Stand; 1992; 76():301-5. PubMed ID: 1478348
[TBL] [Abstract][Full Text] [Related]
2. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
3. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.
Markowitz DG; Goff SP; Bank A
Trans Assoc Am Physicians; 1988; 101():212-8. PubMed ID: 3077729
[TBL] [Abstract][Full Text] [Related]
4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
5. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
[TBL] [Abstract][Full Text] [Related]
6. Generation of high-titer retroviral vectors following receptor-mediated, adenovirus-augmented transfection.
von Rüden T; Stingl L; Cotten M; Wagner E; Zatloukal K
Biotechniques; 1995 Mar; 18(3):484-9. PubMed ID: 7779400
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant human GM-CSF retroviral vector construction and expression in human breast cancer cells].
Zhao M; Mao N; Ba D
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):42-4. PubMed ID: 10743054
[TBL] [Abstract][Full Text] [Related]
8. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
[TBL] [Abstract][Full Text] [Related]
9. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
[TBL] [Abstract][Full Text] [Related]
10. [A study of gene therapy for beta-thalassemia. I. Retroviral-mediated transfer of human beta-globin gene into Friend cells].
Shu H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Aug; 12(4):252-6. PubMed ID: 2147584
[TBL] [Abstract][Full Text] [Related]
11. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
12. Gene delivery by retroviruses.
Deregowski V; Canalis E
Methods Mol Biol; 2008; 455():157-62. PubMed ID: 18463818
[TBL] [Abstract][Full Text] [Related]
13. Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.
Printz M; Reynolds J; Mento SJ; Jolly D; Kowal K; Sajjadi N
Gene Ther; 1995 Mar; 2(2):143-50. PubMed ID: 7719931
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
16. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Ghani K; Cottin S; Kamen A; Caruso M
Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
[TBL] [Abstract][Full Text] [Related]
17. Design of retroviral vectors and helper cells for gene therapy.
Hu WS; Pathak VK
Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508
[TBL] [Abstract][Full Text] [Related]
18. Detection of replication competent retrovirus and lentivirus.
Sastry L; Cornetta K
Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
[TBL] [Abstract][Full Text] [Related]
19. Characterization of transient expression system for retroviral vector production.
Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors.
Ramsey WJ; Caplen NJ; Li Q; Higginbotham JN; Shah M; Blaese RM
Biochem Biophys Res Commun; 1998 May; 246(3):912-9. PubMed ID: 9618311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]